Janka HU, Plewe G., Riddle MC, Kliebe-Frisch C., Schweitzer MA, Yki-Jarvinen H.Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care. 2005;28:254-259.
2.
Schwartz S., Sievers R., Strange P., Lyness WH, Hollander P.; INS-2061 Study Team. Insulin 70/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: efficacy, safety, and cost analysis. Diabetes Care. 2003;26:2238-2243.
3.
Funnell MM, Kruger DF, Spencer M.Self-management support for insulin therapy in type 2 diabetes. Diabetes Educ. 2004;30: 272-280.
4.
Yki-Jarvinen H., Alvarsson M., Bystedt T., et al. A randomized trial comparing initiation of basal insulin individually and in groups in type 2 diabetes mellitus (T2DM). Abstracts of the 66th Scientific Sessions of the ADA. Diabetes.2006;55(suppl 1):A30. Abstract 125-OR.
5.
Yki-Jarvinen H., Dressler A., Ziemen M.; HOE 901/3002 Study Group. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care. 2000;23:1130-1136.
